These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 22061179

  • 1. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
    Carmant L.
    Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
    [Abstract] [Full Text] [Related]

  • 2. Non-vision adverse events with vigabatrin therapy.
    Walker SD, Kälviäinen R.
    Acta Neurol Scand Suppl; 2011; (192):72-82. PubMed ID: 22061182
    [Abstract] [Full Text] [Related]

  • 3. Vigabatrin for infantile spasms.
    Pesaturo KA, Spooner LM, Belliveau P.
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ, Edwards SW, Alber FD, Hancock E, Johnson AL, Kennedy CR, Likeman M, Lux AL, Mackay M, Mallick AA, Newton RW, Nolan M, Pressler R, Rating D, Schmitt B, Verity CM, Osborne JP, participating investigators.
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
    Djuric M, Kravljanac R, Tadic B, Mrlješ-Popovic N, Appleton RE.
    Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
    [Abstract] [Full Text] [Related]

  • 7. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP.
    Lancet; 2014 Dec; 364(9447):1773-8. PubMed ID: 15541450
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of West syndrome].
    Cvitanović-Sojat L, Gjergja R, Sabol Z, Hajnzić TF, Sojat T.
    Acta Med Croatica; 2005 Dec; 59(1):19-29. PubMed ID: 15813352
    [Abstract] [Full Text] [Related]

  • 9. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP, United Kingdom Infantile Spasms Study.
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [Abstract] [Full Text] [Related]

  • 10. Vigabatrin: 2008 update.
    Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD.
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R.
    Drug Saf; 2001 Feb; 24(11):813-28. PubMed ID: 11665869
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vigabatrin monotherapy for infantile spasms.
    Gaily E.
    Expert Rev Neurother; 2012 Mar; 12(3):275-86. PubMed ID: 22364326
    [Abstract] [Full Text] [Related]

  • 15. Treatment of infantile spasms.
    Haines ST, Casto DT.
    Ann Pharmacother; 1994 Jun; 28(6):779-91. PubMed ID: 7919570
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of infantile spasms.
    Hancock EC, Osborne JP, Edwards SW.
    Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD001770. PubMed ID: 23740534
    [Abstract] [Full Text] [Related]

  • 20. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD, Li M, Tsao J, Zhou R, Wu YW, Sankar R, Wu JY, Hussain SA.
    Epilepsy Behav; 2016 Apr 05; 57(Pt A):29-33. PubMed ID: 26921595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.